Abstract: The present invention concerns an enzymatic oxidative deamination process of a dipeptide monomer to prepare an intermediate useful to prepare compounds having endopeptidase and angiotensin converting enzyme inhibition activity.
Type:
Grant
Filed:
April 26, 2001
Date of Patent:
November 18, 2003
Assignee:
Bristol-Myers Squibb Company
Inventors:
Ramesh N. Patel, Amit Banerjee, Venkata B. Nanduri, Steven L. Goldberg, Robert M. Johnston